Transcutaneous Carbon Dioxide Treatment Is Capable of Reducing Peripheral Vascular Resistance in Hypertensive Patients
Open Access
- 22 October 2018
- journal article
- research article
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 32 (6) , 1555-1559
Abstract
Aim: We aimed to investigate the effects of a single carbon dioxide (CO2) treatment on arterial stiffness by monitoring the changes of aortic pulse-wave velocity (PWV) and aortic augmentation index (AIXao), which are indicators of arterial stiffness. Patients and Methods: PWV and AIXao were measured by an invasively validated oscillometric device. The measurements of stiffness parameters were performed before the CO2 treatment, and at 1, 4 and 8 h after the first treatment. Results: Thirty-one patients were included. No significant changes were found in PWV. AIXao decreased significantly 1 h and 4 h after CO2 treatment compared to baseline values (p=0.034 and p2 treatment, but remained significantly lower than baseline AIXao values (p=0.016). Conclusion: CO2 treatment is capable of reducing peripheral vascular resistance. We hypothesize that CO2 is not only a temporal vasodilator but is also capable of activating vasodilation pathways.Keywords
This publication has 20 references indexed in Scilit:
- Transcutaneous carbon dioxide application with hydrogel prevents muscle atrophy in a rat sciatic nerve crush modelJournal of Orthopaedic Research, 2017
- Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk chartsJournal Of Hypertension, 2012
- Type 2 Diabetes Is Associated With Increased Pulse Wave Velocity Measured at Different Sites of the Arterial System but Not Augmentation Index in a Chinese PopulationClinical Cardiology, 2011
- Direct evidence of the vasodilator action of carbon dioxide on subcutaneous microvasculature in rats by use of intra-vital video-microscopyJournal of Biorheology, 2010
- Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocityJournal Of Hypertension, 2010
- Aortic Augmentation Index: Reference Values in a Large Unselected Population by Means of the SphygmoCor DeviceAmerican Journal of Hypertension, 2010
- Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel designVasa, 2009
- Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventionsEuropean Heart Journal, 2005
- Microcirculatory and clinical effects of serial percutaneous application of carbon dioxide in primary and secondary Raynaud’s phenomenonVasa, 2005
- Carbon Dioxide Therapy in the Treatment of Localized Adiposities: Clinical Study and Histopathological CorrelationsAesthetic Plastic Surgery, 2001